UPSI Digital Repository (UDRep)

Synthesis and biological evaluation of hydantoin derivatives as potent antiplasmodial agents

AVAILABLE Article 260 Views
Scan QR Code to share or view item link:

Digital Assets & Download Files
Login required to access this item.
General Information Cached
Title
Synthesis and biological evaluation of hydantoin derivatives as potent antiplasmodial agents
Type
Article
Main Author
Mohd Azlan Nafiah
Subject
Q Science (General)
ISBN
0960894X
Language Code
eng
Bibliographic Details
Place of Production
Tanjung Malim
Publisher
Fakulti Sains & Matematik
Year of publication
2024
Notes
Bioorganic and Medicinal Chemistry Letters
Dissertation Note
Other
Degree Type
Others
Corporate Name
Universiti Pendidikan Sultan Idris

Abstract

Malaria, a devastating disease, has claimed numerous lives and caused considerable suffering, with young children and pregnant women being the most severely affected group. However, the emergence of multidrug-resistant strains of Plasmodium and the adverse side effects associated with existing antimalarial drugs underscore the urgent need for the development of novel, well-tolerated, and more efficient drugs to combat this global health threat. To address these challenges, six new hydantoins derivatives were synthesized and evaluated for their in vitro antiplasmodial activity. Notably, compound 2c exhibited excellent inhibitory activity against the tested Pf3D7 strain, with an IC50 value of 3.97 ± 0.01 nM, three-fold better than chloroquine. Following closely, compound 3b demonstrated an IC50 value of 27.52 ± 3.37 µM against the Pf3D7 strain in vitro. Additionally, all the hydantoins derivatives tested showed inactive against human MCR-5 cells, with an IC50 value exceeding 100 μM. In summary, the hydantoin derivative 2c emerges as a promising candidate for further exploration as an antiplasmodial compound. © 2024 Elsevier Ltd

References

World Health Organization. World Malaria Report 2022. https://www.who.int/ teams/global-malaria-programme/reports/world-malaria-report-2022.

Sato S. Plasmodium—a brief introduction to the parasites causing human malaria and their basic biology. J Physiol Anthropol. 2021;40:1. https://doi.org/10.1186/s40101-020-00251-9.

Kelly-Hope LA, Hemingway J, McKenzie FE. Environmental factors associated with the malaria vectors Anopheles gambiae and Anopheles funestus in Kenya. Malar J. 2009;8:1. https://doi.org/10.1186/1475-2875-8-268.

Ericsson, C.D. Steffen R., Stauffer W., Fischer P.R. Diagnosis and Treatment of Malaria in Children, Clin Infect Dis 2003; 37:10:1340–1348. https://academic.oup.com/cid/article/37/10/1340/451166.

Wellems TE, Plowe C. Chloroquine-resistant Malaria. J Infect Dis. 2001;184:770–776. http://jid.oxfordjournals.org/.

Neill PM, Ward SA, Berry NG, et al. A medicinal chemistry perspective on 4-aminoquinoline Antimalarial drugs. Curr Top Med Chem. 2006;6:479–507.

Perucca E. Clinically relevant drug interactions with antiepileptic drugs. Br J Clin Pharmacol. 2006;61:246–255. https://doi.org/10.1111/j.1365-2125.2005.02529.x.

Mcosker CC, Fitzpatrick PM. Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens. J Antimicrob Chemother.1994;33. http://jac.oxfordjournals.org/.

See S, Ginzburg R. Skeletal muscle relaxants. Pharmacotherapy. 2008;28:207–213. https://doi.org/10.1592/phco.28.2.207.

Harris MG, Stephen G, Faulds CD, Chrisp P. Nilutamide a review of its Pharmacodynamic and Pharmacokinetic properties, and therapeutic efficacy in prostate cancer. Drugs Aging. 1993;3:170.

Abrol R, Page RL. Azimilide dihydrochloride: a new class III anti-arrhythmic agent. Expert Opin Invest Drugs. 2000;9:2705–2715. http://www.ashley-pub.com.

Pitts NE, Vreeland F, Shaw GL, et al. Clinical experience with sorbinil-an aldose reductase inhibitor. Metabolism. 1986;35:96–100.

Meyers MJ, Tortorella MD, Xu J, et al. Evaluation of aminohydantoins as a novel class of antimalarial agents. ACS med Chem Lett. 2014;5:89–93. https://doi.org/10.1021/ml400412x.

Chin E, Tan S, Liew S, Kurz T. Synthesis and Characterization of amino acidderived hydantoins. Malays J Chem. 2021;23:2.

Zakiah M, Syarif R, Mustofa M, Jumina J, Fatmasari N, Sholikhah E. In vitro antiplasmodial, heme Polymerization, and cytotoxicity of hydroxyxanthone derivatives. J Trop Med. 2021:1–11.

Amit A., Bandana K. T., Rawat M. S. M. ‘Synthesis, Antibacterial Screening and Theoretical Molecular Properties Prediction of Hydantoin-chalcone Conjugates.’ 2014;91:1525-1531.

Fujisaki F., Aki H., Naito A., Fukami E., Kashige N., Miake F., Sumoto K., 2014. Synthesis of New 5-Substituted Hydantoins and Symmetrical Twin-Drug Type Hydantoin Derivatives. Chem Pharm Bull 2014; 62: 5: 429-438.

Hidayat I., Thu Y., St. C Black D., Read R. Biological evaluation of certain substituted hydantoins and benzalhydantoins against microbes. IOP Conference Series: Mater Sci Eng, 2016;107:012058.

Liu J, Zhang K, Mai X, et al. Synthesis, anticancer evaluation and docking study of 3- benzyloxyhydantoin derivatives. J Med Chem. 2016;12:37–47.

Su M, Xia D, Teng P, et al. Membrane-active hydantoin derivatives as antibiotic agents. J Med Chem. 2017;60:8456–8465.

Zhang M, Liang Y, Li H, Liu M, Wang Y. Design, synthesis, and biological evaluation of hydantoin bridged analogues of combretastatin A-4 as potential anticancer agents. Bioorg Med Chem. 2017;25:6623–6634.

Ovung A, Bhattacharyya J. Sulfonamide drugs: structure, antibacterial property, toxicity, and biophysical interactions. Biophys Rev. 2021;29:259–272. https://doi.org/10.1007/s12551-021-00795-9.

Thach TD, Nguyen TMT, Nguyen TAT, et al. Synthesis and antimicrobial, antiproliferative and anti-inflammatory activities of novel 1,3,5-substituted pyrazoline sulfonamides. Arab J Chem. 2021;14:103408–103419. https://doi.org/10.1016/j.arabjc.2021.103408.

Li JJ, Anderson D, Burton EG, et al. 1,2-Diarylcyclopentenes as selective cyclooxygenase-2 inhibitors and orally active anti-inflammatory agents. J Med Chem. 1995;38:4570–4578. https://doi.org/10.1021/jm00022a023.

Ahmed, N.M., Lotfallah, A. H., Gaballah, M. S., Awad, S. M., Soltan, M. K. Novel 2- thiouracil-5-sulfonamide derivatives: Design, synthesis, molecular docking, and biological evaluation as antioxidants with 15-LOX inhibition. Molecules 2023; 28: 1925-1948. https://doi.org/10.3390%2Fmolecules28041925.

Sowa T, Menju T, Chen-Yoshikawa FT, et al. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression. Cancer Med. 2017;6:288–297. https://doi.org/10.1002/cam4.991.


Installed and configured by Bahagian Automasi, Perpustakaan Tuanku Bainun, Universiti Pendidikan Sultan Idris
If you have enquiries, kindly contact us at pustakasys@upsi.edu.my or 016-3630263. Office hours only.